Several stocks saw sharp gains driven by key company developments. bioAffinity Technologies surged 63.55% after securing a Hong Kong patent for its lung cancer diagnostic technology, boosting its Asian market position. Antelope Enterprise Holdings rose 33.30% following a $6 million convertible promissory note offering, strengthening its finances. Aethlon Medical jumped 370% after announcing a merger with North Immunology, which is developing a new antibody treatment. Other gains in CID HoldCo and Schrödinger were less clearly linked to specific catalysts. These moves highlight how patents, financing, and mergers can significantly impact stock prices.
The recent stock market gainers and their key catalysts provide context for health-sector stocks on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Sep 18, 2026 03:42 WIB: Among 91 priced health-sector US stocks, 60 rose and 30 fell today. Notably, Sana Biotechnology Inc (SANA) rose 6.34% to USD 3.10 with a typical hold time of 22 days and a Pluang order activity of 71% Buy. Inovio Pharmaceuticals Inc (INO) increased 5.65% to USD 1.22, held typically for 42 days, with 84% Buy orders. Meanwhile, 10X Genomics Inc (TXG) gained 5.48% to USD 76.66, held for 94 days on average, and saw 100% Buy orders on Pluang.
In Q3 2026, websites on Cloudflare's network blocked 13.47% of AI crawler requests, more than double the 5.98% blocked a year earlier. This rise in access denial affects how brands appear in AI-generated answers from platforms like ChatGPT, Gemini, a...
JPMorgan Asset Management (Canada) announced the final cash distributions for September 2026 for three of its ETFs traded on the Toronto Stock Exchange. Unitholders of record on October 19, 2026, will receive payments on October 23, 2026. The ETFs an...
Stillwater Critical Minerals Corp. has upgraded to the OTCQX Best Market from the OTCQB Venture Market, beginning trading under the symbol "PGEZF." This move enhances the company's visibility, liquidity, and accessibility to U.S. investors as it adva...
WasabiCard, a stablecoin-based global payment provider, engaged in key partnership discussions at TOKEN2049 Singapore 2026, focusing on white-label card issuing, global payouts, and embedded payments. The company highlighted growing demand in APAC fo...
The global next generation antibody therapeutics market is projected to increase from $5.45 billion in 2026 to $5.76 billion by 2035, growing at a CAGR of 1%. Growth is fueled by advances in biotechnology, rising demand for targeted therapies, and in...
